Abstract
Multiple sclerosis (MS) is a common neurodegenerative disease that presents after an auto-reactive immune response against constituents of the central nervous system. Demyelination, inflammation, and white matter lesions are all hallmarks of this disease. Clinical research supports the use of mesenchymal stem cells (MSCs) as therapy for MS to ameliorate symptoms and pathology. MSCs can be isolated from multiple tissues, including adipose and bone marrow, and are able to migrate to sites of pathology, release anti-inflammatory factors, and provide immunomodulatory and neuroprotective effects once administered. Numerous studies have demonstrated the beneficial effects of MSCs in experimental autoimmune encephalomyelitis (EAE), an induced model of MS. EAE can be induced in several species; however, the mouse is commonly used for therapeutic testing. In the following chapter, scientists will be able to learn how to prepare reagents and MSCs (e.g., isolate, culture, and expand) as well as skillfully execute induction of EAE in mice and administer stem cell-based treatments. Standard methods used to evaluate the disease progression and analyze postmortem tissues are also included.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Goldenberg M (2012) Multiple sclerosis review. Pharm Therapeut 37:175–184
Ascherio A, Munger KL, Lünemann JD (2012) The initiation and prevention of multiple sclerosis. Nat Rev Neurol 8:602–612
Batoulis H, Addicks K, Kuerten S (2010) Emerging concepts in autoimmune encephalomyelitis beyond the CD4/T(H)1 paradigm. Ann Anat 192:179–193
Lassmann H, van Horssen J (2011) The molecular basis of neurodegeneration in multiple sclerosis. FEBS Lett 585:3715–3723
Lassmann H, van Horssen J, Mahad D (2012) Progressive multiple sclerosis: pathology and pathogenesis. Nat Rev Neurol 8:647–656
Uccelli A, Laroni A, Freedman MS (2012) Mesenchymal stem cells as treatment for MS – progress to date. Mult Scler 19:515–519
Karussis D, Karageorgiou C, Vaknin-Dembinsky A, Gowda-Kurkalli B, Gomori JM, Kassis I et al (2010) Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch Neurol 67:1187–1194
Connick P, Kolappan M, Crawley C, Webber DJ, Patani R, Michell AW et al (2012) Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study. Lancet Neurol 11:150–156
Payne NL, Sun G, McDonald C, Layton D, Moussa L, Emerson-Webber A et al (2012) Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination. Cell Transplant 22:1409–1425
Foust KD, Wang X, McGovern VL, Braun L, Bevan AK, Haidet AM et al (2010) Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN. Nat Biotechnol 28:271–274
Krampera M, Cosmi L, Angeli R, Pasini A, Liotta F, Andreini A et al (2006) Role for interferon-gamma in the immuno-modulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 24:386–398
Freedman MS, Bar-Or A, Atkins HL, Karussis D, Frassoni F, Lazarus H et al (2010) The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group. Mult Scler 16:503–510
Kassis I, Grigoriadis N, Gowda-Kurkalli B, Mizrachi-Kol R, Ben-Hur T, Slavin S et al (2008) Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis. Arch Neurol 65:753–761
Bai L, Lennon DP, Eaton V, Maier K, Caplan AI, Miller SD et al (2009) Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia 57:1192–1203
Zappia E, Casazza S, Pedemonte E, Benvenuto F, Bonanni I, Gerdoni E et al (2005) Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106:1755–1761
Constantin G, Marconi S, Rossi B, Angiari S, Calderan L, Anghileri E et al (2009) Adipose-derived mesenchymal stem cells ameliorate chronic experimental auto-immune encephalomyelitis. Stem Cells 27:2624–2635
Morando S, Vigo T, Esposito M, Casazza S, Novi G, Principato MC et al (2012) The therapeutic effect of mesenchymal stem cell transplantation in experimental autoimmune encephalomyelitis is mediated by peripheral and central mechanisms. Stem Cell Res Ther 3:3
Bernard CC, Carnegie PR (1975) Experimental autoimmune encephalo-myelitis in mice: immunologic response to mouse spinal cord and myelin basic proteins. J Immunol 114:1537–1540
Scruggs BA, Semon JA, Zhang X, Zhang S, Bowles AC, Pandey AC et al (2013) Age of donor reduces the ability of human adipose-derived stem cells to alleviate symptoms in the experimental autoimmune encephalo-myelitis mouse model. Stem Cells Transl Med 2:797–807
Scruggs BA, Bowles AC, Zhang X, Semon JA, Kyzar EJ, Myers L et al (2013) High-throughput screening of stem cell therapy for globoid cell leukodystrophy using automated neuro-phenotyping of twitcher mice. Behav Brain Res 236:35–47
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Bowles, A.C., Scruggs, B.A., Bunnell, B.A. (2014). Mesenchymal Stem Cell-Based Therapy in a Mouse Model of Experimental Autoimmune Encephalomyelitis (EAE). In: Christ, B., Oerlecke, J., Stock, P. (eds) Animal Models for Stem Cell Therapy. Methods in Molecular Biology, vol 1213. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1453-1_25
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1453-1_25
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-1452-4
Online ISBN: 978-1-4939-1453-1
eBook Packages: Springer Protocols